"Weight Loss Pill from Structure Therapeutics Trimmed The Most Pounds Yet. Is The Biotech A Takeover Candidate?" - Barron's

Structure Therapeutics has reported significant results from its weight loss pill trial, achieving the highest weight loss figures to date. The success of this product has led to speculation about the company being a potential takeover candidate in the biotech sector. The stock ticker for Structure Therapeutics is GPCR.